NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
12.13
-0.21 (-1.67%)
Dec 8, 2025, 2:38 PM EST - Market open
NextCure Market Cap
NextCure has a market cap or net worth of $41.1 million as of December 8, 2025. Its market cap has increased by 12.02% in one year.
Market Cap
41.10M
Enterprise Value
18.22M
1-Year Change
12.02%
Ranking
Category
Stock Price
$12.13
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $41.10M, a decrease of -90.59%. That is a compound annual growth rate of -30.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 41.79M | 93.55% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | 300.33M | -80.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |